Forced degradation studies are critical in therapeutic antibody research, helping to evaluate stability across the product lifecycle. Common degradation pathways include aggregation, deamidation, oxidation, and fragmentation, with thermal stress being a frequently studied factor.
This application note explores the stability of a bispecific antibody targeting mouse CD200 and CD47 under thermal stress, using a high-throughput, no-wash HTRF™ assay to assess its binding activity.
Read this application note to learn more.
For research use only. Not for use in diagnostic procedures.
High throughput platforms to characterize a bispecific antibody subjected to force degradation